<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00943969</url>
  </required_header>
  <id_info>
    <org_study_id>CPP 0911965</org_study_id>
    <nct_id>NCT00943969</nct_id>
  </id_info>
  <brief_title>Determinants of Oral Morphine Answer Among Obese Patients Before and After Gastric Bypass</brief_title>
  <acronym>OBEMO</acronym>
  <official_title>Determinants of Oral Morphine Answer Among Obese Patients Before and After Gastric Bypass</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Lariboisière</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Lariboisière</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The bariatric surgery is widely used to treat obesity. Roux-en-Y gastric bypass is one of the
      most frequently surgical methods performed and combines restrictive and malabsorptive
      procedures. Different data suggest that this surgery may modify drug absorption and we think
      it would be clinically relevant to describe the consequences of gastric bypass on drug
      systemic exposure in obese patients, since no data on the comparison between the
      pharmacokinetics (PK) of a drug before and after surgery are available and help to predict
      the drugs posology.The investigators decided to study the morphine because there is a lack of
      information about the PK, pharmacodynamics (PD) et pharmacogenetics (PG) of morphine in obese
      subjects, in contrary with anaesthetic drugs. This is a drug with a narrow therapeutic range
      frequently prescribed in obese patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>30mg Oral morphine systemic exposure (AUC 0-24)</measure>
    <time_frame>Before surgery-7-15 days after surgery- 6 months after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morphine and M6G AUC, clearance, Cmax and Tmax</measure>
    <time_frame>Before surgery-7-15 days after surgery- 6 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fat mass and total body water (assessed by DEXA and BIA)</measure>
    <time_frame>before surgery and 6 months following surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mRNA and protein expression of P-gp , UGT2B7, MRP2 and MRP3 in intestinal biopsies</measure>
    <time_frame>obtained from the bariatric surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>genetic polymorphisms known to affect expression and/or activity of enzymes, receptors and transporters involved in morphine PK/PD (UGT2B7, P-gp, OPRM1, COMT) and morphine PK/PD</measure>
    <time_frame>Before surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>obemo</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>gastric bypass</intervention_name>
    <description>gastric bypass combines restrictive and malabsorptive procedures</description>
    <arm_group_label>obemo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged between 18 and 60 years old.

          -  Patients with morbid obesity (IMC &gt; 40 kg/m²) or severe obesity (IMC=35-40 kg/m²) with
             co morbidities (sleep apnea syndrome or hypertension or steatosis hepatitis) with a
             favourable decision of a multidisciplinary team for a gastric bypass.

          -  Patient agreeing to go 3 times for a one day hospitalisation in the URT of the
             Lariboisière Hospital for the morphine PK/PD.

          -  Patient with a previous medical examination.

          -  Patient giving its well-informed and free consent after information.

        Exclusion Criteria:

          -  diabetes

          -  concomitant sedative, antidepressive or analgesic treatments or drugs unadvised with
             morphine

          -  untreated sleep apnea syndrom, hypoxia (PaO2&lt;70mmHg) or hypercapnia (PaCO2&gt;45mmHg),
             anaemia &lt;10g/dL, ASAT or ALAT&gt;3N
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Célia LLoret Linares</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Unit of Therapeutic Research, Department of Internal Medicine, Lariboisière Hospital</name>
      <address>
        <city>Paris cedex 10</city>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 21, 2009</study_first_submitted>
  <study_first_submitted_qc>July 21, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2009</study_first_posted>
  <last_update_submitted>December 14, 2015</last_update_submitted>
  <last_update_submitted_qc>December 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hopital Lariboisière</investigator_affiliation>
    <investigator_full_name>Célia LLORET LINARES</investigator_full_name>
    <investigator_title>MCU-PH</investigator_title>
  </responsible_party>
  <keyword>obesity</keyword>
  <keyword>gastric bypass</keyword>
  <keyword>morphine</keyword>
  <keyword>pharmacokinetic</keyword>
  <keyword>absorption</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

